Holen Sie sich die Stockscreener-App
5.89
6.33%
0.36
Handel nachbörslich:
5.81
-0.08
-1.36%
Schlusskurs vom Vortag:
$5.53
Offen:
$5.32
24-Stunden-Volumen:
102.94M
Relative Volume:
3.62
Marktkapitalisierung:
$2.52B
Einnahmen:
$64.60M
Nettoeinkommen (Verlust:
$-377.75M
KGV:
-3.80
EPS:
-1.55
Netto-Cashflow:
$-335.64M
1W Leistung:
+12.43%
1M Leistung:
+21.74%
6M Leistung:
+6.72%
1J Leistung:
-12.50%
1-Tages-Spanne:
$5.07
$6.00
1-Wochen-Bereich:
$5.07
$6.30
52-Wochen-Spanne:
$3.79
$12.36
Recursion Pharmaceuticals Inc Stock (RXRX) Company Profile
Firmenname
Recursion Pharmaceuticals Inc
Sektor
Branche
Telefon
(385) 269-0203
Adresse
41S RIO GRANDE STREET, SALT LAKE CITY
Vergleichen Sie RXRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RXRX
Recursion Pharmaceuticals Inc
|
5.89 | 2.41B | 64.60M | -377.75M | -335.64M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Recursion Pharmaceuticals Inc Stock (RXRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-05-22 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-03-16 | Eingeleitet | Needham | Buy |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-04-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-03-04 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-09-21 | Eingeleitet | Berenberg | Buy |
| 2021-05-11 | Eingeleitet | BofA Securities | Buy |
| 2021-05-11 | Eingeleitet | Goldman | Neutral |
| 2021-05-11 | Eingeleitet | JP Morgan | Neutral |
| 2021-05-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2021-05-11 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Recursion Pharmaceuticals Inc Aktie (RXRX) Neueste Nachrichten
Recursion Pharmaceuticals Stock (RXRX) Opinions on Recent Price Momentum - Quiver Quantitative
Absci Stock Offers High-Risk AI Biotech Exposure With 110% Upside Forecast - Investing.com
Recursion Pharmaceuticals Inc. stock volume spike explainedShort Setup & AI Enhanced Trade Execution Alerts - newser.com
Signal strength of Recursion Pharmaceuticals Inc. stock in tech scannersWeekly Risk Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Advanced analytics toolkit walkthrough for Recursion Pharmaceuticals Inc.Weekly Market Report & Daily Profit Maximizing Trade Tips - newser.com
Is Recursion Pharmaceuticals on a Comeback Trail? - StocksToTrade
Best Biotech Stocks To ConsiderOctober 9th - MarketBeat
Using economic indicators to assess Recursion Pharmaceuticals Inc. potentialJuly 2025 Patterns & Free Fast Entry Momentum Trade Alerts - newser.com
Will Recursion Pharmaceuticals Inc. stock maintain growth story2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
Recursion Pharmaceuticals Hits Day High with 16.44% Surge in Stock Price - Markets Mojo
Costco, AMD, Recursion Pharmaceuticals, Cipher Mining And Snowflake: Why These 5 Stocks Are On Investors' Radars Today - AOL.com
Promising Biotech Stocks To Follow NowOctober 11th - MarketBeat
Recursion Pharmaceuticals (RXRX): Assessing Valuation with AI Strategy in Focus Ahead of Key CEO Presentation - Yahoo Finance
Where Will Recursion Pharmaceuticals Be in 5 Years? - MSN
How Investors Are Reacting To Recursion Pharmaceuticals (RXRX) AI Platform Spotlight Ahead of CEO's Dubai Talk - simplywall.st
Biotech Stocks To Follow TodayOctober 8th - MarketBeat
RXRX Stock: What’s Behind Recent Moves? - timothysykes.com
Recursion Pharmaceuticals (RXRX): Evaluating Valuation Ahead of CEO’s AI Conference Appearance and Growth Plans - simplywall.st
Recursion Stock: Can It Bounce Back? - StocksToTrade
Recursion Pharmaceuticals’ Stocks: A Deep Dive - timothysykes.com
Assessing Recursion Pharmaceuticals After Shares Surge 19% Amid AI-Driven Market Optimism - simplywall.st
Recursion Pharmaceuticals: Recent Gains Mysterious Given Lack Of Overall Progress (RXRX) - Seeking Alpha
AI Drug Discovery Goldmine? Inside Recursion Pharma’s Wild Stock Surge and What’s Next - ts2.tech
Weiss Ratings Reiterates "Sell (D-)" Rating for Recursion Pharmaceuticals (NASDAQ:RXRX) - MarketBeat
Recursion Pharmaceuticals (RXRX) Climbs 16% Ahead of AI Conference - Yahoo Finance
Why Recursion Pharmaceuticals Stock Tanked on Tuesday - MSN
COST, AMD, RXRX, CIFR, SNOW: 5 Trending Stocks TodayAdvanced Micro Devices (NASDAQ:AMD) - Benzinga
Best Pharmaceutical Stocks To Watch NowOctober 8th - MarketBeat
What's Going On With Recursion Pharmaceuticals Stock On Wednesday? - Benzinga
Investors Buy Large Volume of Recursion Pharmaceuticals Call Options (NASDAQ:RXRX) - MarketBeat
Recursion Pharmaceuticals (NASDAQ:RXRX) Trading Up 5.8%Here's What Happened - MarketBeat
Recursion Pharmaceuticals Shares Surge Amid Strategic Growth - TipRanks
AI Drug Discovery Darling? Recursion Pharma (RXRX) Stock’s Wild Ride in 2025 - ts2.tech
Recursion Pharmaceuticals, Inc. (RXRX): A Bull Case Theory - Yahoo Finance
Recursion Pharmaceuticals Experiences Evaluation Revision Amidst Market Dynamics and Performance Indicators - Markets Mojo
Recursion Pharmaceuticals (RXRX) Dips More Than Broader Market: What You Should Know - sharewise.com
RXRX Shares Plunge: Time to Bail Out? - StocksToTrade
Needham Reiterates a Buy on Recursion Pharmaceuticals (RXRX) - MSN
Can Recursion Pharmaceuticals Inc. recover in the next quarterJuly 2025 Analyst Calls & Safe Capital Allocation Plans - newser.com
Custom strategy builders for tracking Recursion Pharmaceuticals Inc.2025 Trade Ideas & Weekly Watchlist for Hot Stocks - newser.com
How to recover losses in Recursion Pharmaceuticals Inc. stock2025 Market Sentiment & Verified Technical Trade Signals - newser.com
Is Recursion Pharmaceuticals Inc. still worth holding after the dip2025 Growth vs Value & Fast Exit Strategy with Risk Control - newser.com
Will Recursion Pharmaceuticals Inc. stock recover faster than market2025 Big Picture & Entry and Exit Point Strategies - newser.com
Should you wait for a breakout in Recursion Pharmaceuticals Inc.Trade Entry Summary & Real-Time Buy Zone Alerts - newser.com
Biotech Stocks To Watch NowOctober 4th - MarketBeat
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Why Recursion Pharmaceuticals (RXRX) Is Up 19.2% After Securing $12.5M Milestone in AI Drug Partnership - simplywall.st
Biotech Stocks To ResearchOctober 3rd - MarketBeat
Recursion Pharmaceuticals (RXRX) Surges 8.2%: Is This an Indication of Further Gains? - Nasdaq
Evaluating Recursion After a 19% Rally Amid Renewed Interest in Biotech AI Initiatives - Yahoo Finance
Finanzdaten der Recursion Pharmaceuticals Inc-Aktie (RXRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):